Journal of Hepatology
Volume 51, Issue 4 , Pages 638-639, October 2009

Show me your signaling– and I’ll tell you who you are☆

Department of Internal Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany

published online 27 May 2009.

Associate Editor: K. Koike

Abbreviations: CML, chronic myeloid leukemia, HCC, hepatocellular carcinoma

No abstract is available. To read the body of this article, please view the Full Text online.

 

☆ M.J.S. declared that he does not have anything to disclose regarding funding or conflict of interest with respect to this manuscript. P.R.G. receives lecture and consultant fees from Bayer AG, Leverkusen, Germany.

PII: S0168-8278(09)00376-6

doi:10.1016/j.jhep.2009.05.011

Refers to article:

  • Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo , 12 June 2009

    Pippa Newell, Sara Toffanin, Augusto Villanueva, Derek Y. Chiang, Beatriz Minguez, Laia Cabellos, Radoslav Savic, Yujin Hoshida, Kiat Hon Lim, Pedro Melgar-Lesmes, Steven Yea, Judit Peix, Kemal Deniz, M. Isabel Fiel, Swan Thung, Clara Alsinet, Victoria Tovar, Vincenzo Mazzaferro, Jordi Bruix, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet
    Journal of Hepatology October 2009 (Vol. 51, Issue 4, Pages 725-733)

Journal of Hepatology
Volume 51, Issue 4 , Pages 638-639, October 2009

Article Tools